Market research

Animal Intestinal Health Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

19report chapters

360iResearch introduction

Public research overview

Animal Intestinal Health: Executive Overview

Animal intestinal health encompasses nutrition, microbiome balance, pathogen control, gut-barrier integrity, and digestive performance across livestock, poultry, aquaculture, and companion animals. The field is increasingly connected to antimicrobial stewardship, animal welfare, food safety, and production resilience. Its practical focus is shifting from treating digestive disorders after they emerge toward prevention, monitoring, and management of underlying biological and environmental drivers.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Product Type

    • Enzymes
    • Organic Acids
    • Phytogenics
    • Prebiotics
    More in this chapter
  2. Chapter 8 Animal Type

    • Aquaculture
    • Companion Animals
    • Poultry
    • Ruminants
    More in this chapter
  3. Chapter 9 Formulation

    • Liquid
    • Pellet
    • Powder
    View chapter

Prevention, Precision, and Resilience Are Reshaping Intestinal Health

The landscape is being transformed by stronger scrutiny of antimicrobial use, tighter expectations for traceability and food safety, and growing interest in alternatives such as probiotics, prebiotics, enzymes, organic acids, phytogenic compounds, and targeted nutritional strategies. Producers are also placing greater emphasis on early-life microbiome development, feed quality, water hygiene, housing conditions, vaccination programs, and stress reduction. This integrated approach recognizes that intestinal health depends on interactions among diet, pathogens, immunity, genetics, management, and the surrounding environment.

Artificial Intelligence Is Accelerating Diagnosis and Decision Support

Artificial intelligence is contributing to intestinal-health programs through pattern recognition across feed data, animal performance records, environmental readings, laboratory results, imaging, and microbiome profiles. Properly validated systems can help identify deviations earlier, prioritize animals or herds for investigation, optimize feeding and intervention timing, and support more consistent interpretation of complex biological data. However, effective deployment requires representative datasets, transparent validation, cybersecurity, data governance, and veterinary oversight; AI should support-not replace-clinical judgment and on-farm verification.

Regional Insights: Regulation, Production Systems, and Adoption Priorities Differ

North America is characterized by advanced animal-production systems, strong veterinary infrastructure, and emphasis on antimicrobial stewardship, data-enabled management, and feed efficiency. Latin America combines major livestock and poultry activity with varied regulatory capacity, making biosecurity, affordable interventions, and scalable technical support especially important. Europe places pronounced emphasis on welfare, environmental performance, residue control, and restrictions on routine antimicrobial use. The Middle East prioritizes resilience in challenging climates, water and feed efficiency, and dependable supply chains, while Africa requires solutions adapted to diverse production systems, disease pressures, infrastructure constraints, and smallholder needs. Asia-Pacific spans highly intensive and smallholder operations, with priorities including disease prevention, aquaculture health, food safety, and practical technologies that can operate across wide differences in climate and farm capability.

Group Insights: Policy Alignment and Production Diversity Shape Priorities

ASEAN markets generally require flexible approaches that address tropical disease pressure, aquaculture and poultry production, fragmented supply chains, and differing regulatory systems. BRICS countries represent varied production structures and policy environments, increasing the value of adaptable tools, local validation, and cost-conscious implementation. The European Union emphasizes harmonized food-safety, animal-welfare, environmental, and antimicrobial-responsibility objectives. G7 economies commonly focus on evidence standards, precision livestock management, resilient supply chains, and responsible innovation. GCC markets place particular weight on climate adaptation, water efficiency, biosecurity, and reliable access to feed and animal-health inputs. NATO members span diverse agricultural systems, but shared concerns include biosecurity preparedness, supply continuity, and resilience to cross-border disease risks.

Country Insights: National Context Determines Implementation

Australia’s extensive livestock systems heighten the importance of pasture management, biosecurity, and climate resilience. Brazil requires scalable intestinal-health programs suited to large poultry, swine, cattle, and aquaculture value chains. Canada emphasizes cold-climate management, feed quality, welfare, and responsible antimicrobial use. China combines intensive production with strong attention to food safety, disease control, and digital monitoring. France, Germany, Italy, and Spain reflect European priorities around welfare, environmental performance, traceability, and antimicrobial stewardship. India needs approaches compatible with diverse farm sizes, variable infrastructure, poultry and dairy priorities, and affordability constraints. Japan and South Korea emphasize advanced production management, food safety, and technology-supported monitoring. Mexico benefits from solutions addressing poultry and livestock biosecurity, heat stress, feed consistency, and supply-chain variation. Russia’s priorities include domestic input resilience, animal disease control, and adaptation to regional production conditions. The United Kingdom continues to emphasize welfare, food safety, antimicrobial responsibility, and evidence-based husbandry. The United States combines sophisticated production systems with strong interest in precision management, functional feed ingredients, pathogen reduction, and measurable production outcomes.

Action Agenda for Industry Leaders: Build Verified, Integrated Programs

Industry leaders should begin with clearly defined outcomes-such as reduced digestive disorders, improved feed utilization, stable performance, or lower antimicrobial dependence-and establish baseline measurements before adopting interventions. Programs should combine nutrition, water quality, hygiene, vaccination, environmental control, genetics, and veterinary review rather than relying on a single product category. Leaders should require independent evidence, transparent claims, species-specific validation, and monitoring protocols that distinguish correlation from causation. Investment in interoperable data systems, workforce training, regional pilot programs, and rapid feedback loops can improve implementation. Partnerships with producers, veterinarians, laboratories, regulators, and researchers should be structured around measurable animal-health and food-safety outcomes.

Research Methodology: Evidence-Led Synthesis of Intestinal-Health Drivers

This executive summary uses a structured qualitative synthesis of established animal-health principles, production-system considerations, regulatory themes, and technology applications relevant to animal intestinal health. The framework evaluates interactions among diet, microbiota, immunity, pathogens, management, welfare, environmental conditions, and antimicrobial stewardship across major geographies and country contexts. Regional, group, and country observations are presented as contextual insights rather than quantified market claims. Interpretation should be supplemented with current peer-reviewed studies, official veterinary and food-safety guidance, species-specific field data, and locally validated intervention trials before operational decisions are made.

Conclusion: Intestinal Health Is a System-Level Capability

Animal intestinal health is evolving into a prevention-oriented discipline that links biological performance with welfare, food safety, sustainability, and operational resilience. The strongest programs are likely to combine validated nutritional and management interventions with disciplined biosecurity, reliable diagnostics, responsible antimicrobial practices, and carefully governed digital tools. Because production conditions and regulatory expectations differ across regions, groups, and countries, leaders should prioritize locally tested solutions, measurable outcomes, and continuous learning over universal claims or isolated interventions.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Animal Intestinal Health Market, by Product Type
    1. 7.1Introduction
    2. 7.2Enzymes
      1. 7.2.1Phytase
      2. 7.2.2Protease
      3. 7.2.3Xylanase
    3. 7.3Organic Acids
    4. 7.4Phytogenics
    5. 7.5Prebiotics
    6. 7.6Probiotics
      1. 7.6.1Bacterial Probiotics
      2. 7.6.2Yeast Probiotics
    7. 7.7Yeast & Yeast Derivatives
  8. 8.Animal Intestinal Health Market, by Animal Type
    1. 8.1Introduction
    2. 8.2Aquaculture
      1. 8.2.1Fish
      2. 8.2.2Shrimp
    3. 8.3Companion Animals
      1. 8.3.1Cat
      2. 8.3.2Dog
    4. 8.4Poultry
      1. 8.4.1Broiler
      2. 8.4.2Layer
      3. 8.4.3Turkey
    5. 8.5Ruminants
      1. 8.5.1Beef Cattle
      2. 8.5.2Dairy Cattle
      3. 8.5.3Sheep And Goat
    6. 8.6Swine
      1. 8.6.1Breeder
      2. 8.6.2Grower Finisher
      3. 8.6.3Sow And Piglet
  9. 9.Animal Intestinal Health Market, by Formulation
    1. 9.1Introduction
    2. 9.2Liquid
    3. 9.3Pellet
    4. 9.4Powder
  10. 10.Animal Intestinal Health Market, by Route Of Administration
    1. 10.1Introduction
    2. 10.2In-Feed
    3. 10.3In-Water
    4. 10.4Oral Direct-Dose
      1. 10.4.1Syringes
      2. 10.4.2Capsules & Tablets
      3. 10.4.3Chews
      4. 10.4.4Parenteral
    5. 10.5Injectable Therapies
    6. 10.6Environmental Or Hatchery
    7. 10.7Spray Applications
  11. 11.Animal Intestinal Health Market, by Application
    1. 11.1Introduction
    2. 11.2Feed Additive
    3. 11.3Nutritional Supplement
    4. 11.4Therapeutic
  12. 12.Animal Intestinal Health Market, by Distribution Channel
    1. 12.1Introduction
    2. 12.2Offline
      1. 12.2.1Direct Sales
      2. 12.2.2Distributor
    3. 12.3Online
  13. 13.Animal Intestinal Health Market, by Customer Type
    1. 13.1Introduction
    2. 13.2Integrated Livestock Producers
    3. 13.3Independent Farms & Ranches
    4. 13.4Feed Industry Customers
    5. 13.5Nutrition Companies
    6. 13.6Veterinary Clinics & Hospitals
  14. 14.Animal Intestinal Health Market, by Region
    1. 14.1Introduction
    2. 14.2Asia-Pacific
    3. 14.3North America
    4. 14.4Latin America
    5. 14.5Europe
    6. 14.6Middle East
    7. 14.7Africa
  15. 15.Animal Intestinal Health Market, by Group
    1. 15.1Introduction
    2. 15.2ASEAN
    3. 15.3GCC
    4. 15.4European Union
    5. 15.5BRICS
    6. 15.6G7
    7. 15.7NATO
  16. 16.Animal Intestinal Health Market, by Country
    1. 16.1Introduction
    2. 16.2United States
    3. 16.3Canada
    4. 16.4Mexico
    5. 16.5Brazil
    6. 16.6United Kingdom
    7. 16.7Germany
    8. 16.8France
    9. 16.9Russia
    10. 16.10Italy
    11. 16.11Spain
    12. 16.12China
    13. 16.13India
    14. 16.14Japan
    15. 16.15Australia
    16. 16.16South Korea
  17. 17.Competitive Landscape
    1. 17.1Market Share Analysis, 2025
    2. 17.2Market Concentration Analysis, 2025
      1. 17.2.1Concentration Ratio (CR)
      2. 17.2.2Herfindahl Hirschman Index (HHI)
    3. 17.3Recent Developments & Impact Analysis, 2025
    4. 17.4Product Portfolio Analysis, 2025
    5. 17.5Benchmarking Analysis, 2025
  18. 18.Company Profiles
    1. 18.1Alltech, Inc.
    2. 18.2Anpario plc
    3. 18.3Archer‑Daniels‑Midland Company
    4. 18.4Balchem Corporation
    5. 18.5BASF SE
    6. 18.6BioZyme Incorporated
    7. 18.7Boehringer Ingelheim International GmbH
    8. 18.8Cargill, Incorporated
    9. 18.9Ceva Santé Animale
    10. 18.10Church & Dwight Co., Inc.
    11. 18.11Dr. Eckel Animal Nutrition GmbH & Co. KG
    12. 18.12DSM‑Firmenich AG
    13. 18.13Elanco Animal Health Incorporated
    14. 18.14Evonik Industries AG
    15. 18.15EW Nutrition GmbH
    16. 18.16International Flavors & Fragrances Inc.
    17. 18.17Kemin Industries, Inc.
    18. 18.18Kerry Group plc
    19. 18.19Lallemand Inc.
    20. 18.20Lesaffre International, SAS
    21. 18.21Norel, S.A.
    22. 18.22Nor‑Feed S.A.S.
    23. 18.23Novozymes A/S
    24. 18.24Olmix SA
    25. 18.25Orffa International Holding B.V.
    26. 18.26Phibro Animal Health Corporation
    27. 18.27Vetoquinol SA
    28. 18.28Virbac S.A.
    29. 18.29Vland Biotech Inc.
    30. 18.30Zoetis Inc.
  19. 19.Key Experts

Loading the sample request form…